MENU

INTS Intensity Therapeutics Forecast, Technical & Fundamental Analysis

Industry Biotechnology
INTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
INTS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

INTS is expected to report earnings to fall 2.78% to -34 cents per share on November 11

Intensity Therapeutics INTS Stock Earnings Reports
Q3'24
Est.
$-0.35
Q2'24
Missed
by $0.04
Q4'23
Missed
by $0.05
Q3'23
Missed
by $0.08
Q2'23
Missed
by $1.03
The last earnings report on August 09 showed earnings per share of -36 cents, missing the estimate of -31 cents. With 100.00 shares outstanding, the current market capitalization sits at 52.20M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1 Enterprise Drive
Phone
+1 203 221-7381
Employees
17
Web
https://www.intensitytherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

INTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INTS has been loosely correlated with ACOGF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if INTS jumps, then ACOGF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTS
1D Price
Change %
INTS100%
-3.03%
ACOGF - INTS
34%
Loosely correlated
+4.18%
GBIO - INTS
28%
Poorly correlated
-6.10%
MRKR - INTS
27%
Poorly correlated
-7.67%
ALXO - INTS
26%
Poorly correlated
-3.21%
TSVT - INTS
25%
Poorly correlated
-0.20%
More